Neural Regeneration Research ›› 2017, Vol. 12 ›› Issue (8): 1352-1356.doi: 10.4103/1673-5374.213558

Previous Articles     Next Articles

Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis

John Soltys1, Qin Wang2, Yang Mao-Draayer2   

  1. 1 Present Address: University of Colorado Medical Scientist Training Program (MSTP), Aurora, CO, USA;             
    2 Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA
  • Received:2017-07-22 Online:2017-08-15 Published:2017-08-15
  • Contact: Yang Mao-Draayer, M.D.,Ph.D., maodraay@umich.edu.
  • Supported by:

    This study was funded by an investigator-initiated, unrestricted research grant (to YMD) from Biogen Idec. YMD served as a consultant and/or received grant support from: Acorda, Bayer Pharmaceutical, EMD Serono, Genzyme, Novartis, Questor, Teva Neuroscience and Chugai Pharma. Dr. YMD is currently supported by grants from NIH NIAID Autoimmune Center of Excellence: UM1-AI110557; NIH NINDS R01-NS080821, Novartis and Chugai (to YMD).

Abstract:

Benign multiple sclerosis is a retrospective diagnosis based primarily on a lack of motor symptom progression. Recent findings that suggest patients with benign multiple sclerosis experience non-motor symptoms highlight the need for a more prospective means to diagnose benign multiple sclerosis early in order to help direct patient care. In this study, we present optical coherence tomography and T cell neurotrophin gene analysis findings in a small number of patients with benign multiple sclerosis. Our results demonstrated that retinal nerve fiber layer was mildly thinned, and T cells had a distinct gene expression profile that included upregulation of interleukin 10 and leukemia inhibitory factor, downregulation of interleukin 6 and neurotensin high affinity receptor 1 (a novel neurotrophin receptor). These findings add evidence for further investigation into optical coherence tomography and mRNA profiling in larger cohorts as a potential means to diagnose benign multiple sclerosis in a more prospective manner.

Key words: neurotensin high affinity receptor 1, benign multiple sclerosis, optical coherence tomography, interleukin 10, T cell, leukemia inhibitory factor, optic neuritis, neural regeneration